HHS watchdog office steps up focus on drug pricing
(By Ed Silverman for STAT) Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department
Read More(By Ed Silverman for STAT) Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department
Read MoreIn Karen Tellen-Lawton’s column, she gives a little background information on Medicare in effort to help the reader to understand
Read More(By Julie Rovner for Kaiser Health News) Throughout the campaign, President-Elect Donald Trump’s entire health message consisted of promising to
Read More(By Dylan Scott for STAT) WASHINGTON — Should President Donald Trump make drug makers relieved? Or anxious? Continue reading article here… Notice:
Read More(By Karen Weintraub for STAT) The drug was still experimental, but clinical trials suggested it could be a lifesaver for
Read More(By Ed Silverman for STAT) Cash is not always king. In a move that should settle a highly contentious legal
Read More(By Pauline Bartolone for California Healthline) This year, Mary O’Connor and her father made voting a family affair. O’Connor’s father
Read More(By Ted Slafsky for STAT) Sticker shock over the cost of drugs isn’t going away any time soon. Drug prices
Read More(By Sharon Begley for STAT) Just five months after federal health officials asked hospitals and physicians to be on the
Read More(By Ed Silverman for STAT) The results for nearly half of all clinical trials conducted by big drug makers during
Read More